<p>Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients &lt;12 Years of Age with Hemophilia A (SWIFTLY-HA Study)</p>

Original Research

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)

Total article views		HTML views	PDF downloads	Totals
6,588	Dovepress*	6,241+	518	6,759
	PubMed Central*	347	106	453
	Totals	6,588	624	7,212
*Since 21 June 2021

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
4	0	0	1	1	2